The cost-effectiveness of elective Cesarean delivery for HIV-infected women with detectable HIV RNA during pregnancy

Medicine and Dentistry

• Human Immunodeficiency Virus 100%
• Cesarean Section 63%
• Health Care Cost 45%
• Obstetric Delivery 36%
• Child 36%
• RNA 27%
• Life Expectancy 27%
• Vaginal Delivery 27%
• Mortality Rate 18%
• Maternal Death 18%
• Childbirth 18%
• Pregnancy 9%
• Lifespan 9%
• Maternal Mortality 9%
• Trial of Labor 9%
• Health 9%

Nursing and Health Professions

• Cesarean Section 63%
• Woman 54%
• Obstetric Delivery 36%
• Cost Effectiveness Analysis 27%
• Vaginal Delivery 27%
• RNA 27%
• Life Expectancy 27%
• Mortality Rate 18%
• Quality Adjusted Life Year 18%
• Maternal Death 18%
• Data Base 9%
• Quality of Life 9%
• Hospital Cost 9%
• Tertiary Care Center 9%
• Incremental Cost-Effectiveness Ratio 9%
• Maternal Mortality 9%
• Procedures 9%
• Death 9%

Pharmacology, Toxicology and Pharmaceutical Science

• HIV 100%
• RNA 27%
• Life Expectancy 27%
• Mortality Rate 18%
• Maternal Death 18%
• Death 9%
• Maternal Mortality 9%